Spark Venture Management

Spark Venture Management is a London-based venture capital firm founded in 2005, specializing in early-stage investments primarily in the technology, media, and healthcare sectors across the UK and Europe. With over 12 years of experience, the firm focuses on high-growth potential companies, providing equity investments to support their development from startup to eventual trade sale or initial public offering. Spark Venture Management is committed to leveraging its expertise to foster innovation and drive success in the consumer technology landscape.

Anthony Duffy

Founder and Director

43 past transactions

Unmarshal

Seed Round in 2021
Unmarshal is a decentralized network that specializes in indexing blockchain data and providing tools to support decentralized finance (DeFi) applications across various blockchain platforms. The company offers access to its data through multiple channels, including APIs, push notifications, WebSockets, and analytics. This enables clients to efficiently utilize an indexed database of new chains and protocols, enhancing their operational capabilities. Unmarshal's automated processes operate on a cost-sharing model, allowing for scalable and economical access to essential blockchain data for developers and businesses in the DeFi space.

Study119.com

Seed Round in 2019
Study119.com is a professional firefighter education and training service platform.

MyOffer

Series B in 2018
MyOffer is an online platform that facilitates overseas study applications, primarily focusing on universities in the United Kingdom and Australia. Founded in 2014 and based in London, the company offers a search engine that provides access to over one million courses globally. Its myOffer feature utilizes Big Data and comprehensive analysis to recommend courses and universities tailored to users' academic backgrounds and preferences. In addition to course recommendations, MyOffer aims to guide students on various aspects of studying abroad, including overseas living and studying experiences. The company also plans to expand its services to include visa applications, accommodation, career planning, and employment support for international students. MyOffer operates as a subsidiary of UVIC Limited.

Simba Sleep

Venture Round in 2016
Simba Sleep is a London-based company that specializes in designing and manufacturing mattresses, pillows, duvets, bedding, and bed bases. Founded in 2015, the company combines innovative materials such as precision-engineered foam and patented conical pocket springs to create a range of mattresses that promote comfortable sleep. Simba Sleep emphasizes the importance of quality rest in daily life, aiming to help customers improve their sleep experience. Its products are available for purchase online and in select retail locations, including John Lewis stores in the United Kingdom. Additionally, Simba Sleep offers financing options for customers looking to invest in better sleep.

Simba Sleep

Series A in 2016
Simba Sleep is a London-based company that specializes in designing and manufacturing mattresses, pillows, duvets, bedding, and bed bases. Founded in 2015, the company combines innovative materials such as precision-engineered foam and patented conical pocket springs to create a range of mattresses that promote comfortable sleep. Simba Sleep emphasizes the importance of quality rest in daily life, aiming to help customers improve their sleep experience. Its products are available for purchase online and in select retail locations, including John Lewis stores in the United Kingdom. Additionally, Simba Sleep offers financing options for customers looking to invest in better sleep.

Sky Medical Technology

Seed Round in 2014
Sky Medical Technology Limited develops innovative neuromuscular electro-stimulation medical devices aimed at enhancing vascular health. Their flagship products include the geko device, which stimulates the common peroneal nerve to activate muscle pumps and improve blood flow, and the firefly device, designed for athletes to enhance lower limb circulation for quicker recovery. The company's OnPulse™ therapy represents a significant advancement in bioelectronic medicine, offering clinically proven solutions for various acute and chronic circulatory conditions, including the prevention of blood clots, treatment of swelling post-surgery, and management of non-healing wounds. These devices are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, across NHS and private hospitals, as well as in clinical studies. Sky Medical Technology distributes its products globally, reaching markets in Asia, Europe, the Middle East, and North America. Founded in 2006 and based in High Wycombe, United Kingdom, the company addresses the needs of over forty million individuals facing vascular-related health challenges.

Vigil Monitoring

Series A in 2013
Vigil is a privately owned New Zealand company founded in 2012. Our​ system improves healthcare outcomes in home based personal healthcare management, hospital and managed care environments. Our industry specific hardware and software packages can be tailored to meet individual customer needs and integrated into existing operational systems, improving cost efficiency, quality of care and healthcare outcomes. They are designed operate with different devices and applications, providing end-to-end connectivity that means device users [wearers], their friends and family and other service providers [carers] can easily access data about the wearer, their wellbeing, their location and their environment.

Haemostatix

Venture Round in 2012
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Zilico

Venture Round in 2012
Zilico Limited is a Manchester-based company focused on developing diagnostic devices aimed at improving cancer detection, particularly cervical cancer. Utilizing electrical impedance spectroscopy technology, Zilico's flagship product, ZedScan, operates alongside colposcopy to provide real-time, objective assessments of cervical epithelial tissue. This technology addresses the limitations of traditional diagnostic methods, which often involve subjective interpretations. Zilico is actively working on two applications: one targeting the referral market and another aimed at the screening market, both designed to enhance diagnostic accuracy and reduce the subjectivity associated with current practices. Since its founding in 2006, Zilico has aimed to deliver significant health economic benefits and improve cancer screening programs. The company was previously known as Aperio Diagnostics Limited before rebranding in 2008.

Oxford Immunotec

Venture Round in 2012
Oxford Immunotec Limited is a medical diagnostics company that specializes in the development and commercialization of innovative tests for infectious and immunological diseases, leveraging its patented T-SPOT technology. This technology enables the measurement of T cell responses at a single-cell level, which aids in the diagnosis, prognosis, and monitoring of conditions regulated by the immune system. The company offers the T-SPOT.TB test, a cellular blood test designed to detect both active and latent tuberculosis infections. Additionally, it operates testing laboratories in the United States and the United Kingdom, providing access to various immunological tests for healthcare providers. Founded in 2002 and headquartered in Abingdon, United Kingdom, with operations in Marlborough, Massachusetts, Oxford Immunotec Limited serves a diverse clientele, including independent laboratories, hospital systems, and public and private institutions across the United States and internationally.

Alchemy Pharmatech

Venture Round in 2012
Alchemy Pharmatech Ltd is a UK-based company focused on developing innovative drug delivery platforms, particularly intranasal delivery devices for administering dry powders. Established in 2012 and located in Runcorn, the company creates needle-free solutions designed to ensure smooth and consistent delivery, minimizing inter-operator variability. Its product portfolio encompasses a range of applications, including generic medicines, vaccines, hormone replacement therapies, and pain management solutions for both human and animal health. By collaborating with the pharmaceutical industry, Alchemy Pharmatech aims to enhance treatment efficacy and patient comfort through its advanced delivery technologies.

Celoxica

Venture Round in 2012
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Haemostatix

Series C in 2011
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Vivacta

Venture Round in 2010
Vivacta Limited is a medical diagnostics company based in Sittingbourne, UK, specializing in point-of-care testing solutions. The company has created an innovative piezofilm technology platform that enhances the development of near-patient diagnostic products, achieving sensitivity and dynamic range comparable to laboratory tests. Vivacta has successfully developed a diagnostic test for thyroid stimulating hormone (TSH) and is currently focused on creating a multiple analyte cardiovascular diagnostic test. This test aims to facilitate rapid diagnosis in emergency and acute care settings, addressing the urgent need for timely detection of potential heart attacks and related medical conditions.

Haemostatix

Venture Round in 2010
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Celoxica

Venture Round in 2010
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Oxford Immunotec

Series D in 2010
Oxford Immunotec Limited is a medical diagnostics company that specializes in the development and commercialization of innovative tests for infectious and immunological diseases, leveraging its patented T-SPOT technology. This technology enables the measurement of T cell responses at a single-cell level, which aids in the diagnosis, prognosis, and monitoring of conditions regulated by the immune system. The company offers the T-SPOT.TB test, a cellular blood test designed to detect both active and latent tuberculosis infections. Additionally, it operates testing laboratories in the United States and the United Kingdom, providing access to various immunological tests for healthcare providers. Founded in 2002 and headquartered in Abingdon, United Kingdom, with operations in Marlborough, Massachusetts, Oxford Immunotec Limited serves a diverse clientele, including independent laboratories, hospital systems, and public and private institutions across the United States and internationally.

Academia.edu

Angel Round in 2010
Academia.edu is the largest and fastest-growing platform in the world for sharing academic research. Its mission is to accelerate and democratize academic research. Over 150 million academics have signed up to Academia.edu, adding 25 million papers. Over 100,000 people join Academia.edu each day. Academia.edu attracts over 52 million unique visitors a month. 40% of the world's faculty log in to Academia.edu every month. The company was founded in 2008 and is headquartered in San Francisco, California.

Celona Techlogies

Venture Round in 2010
Celona Technologies Ltd. specializes in business-centric application data migration software designed to facilitate significant organizational changes. The company offers a range of tailored software solutions that enable the seamless migration of applications, data, users, and processes without downtime. Key products include Celona Evolve, which manages the migration and bi-directional synchronization of application data and business processes, alongside features such as a management dashboard, migration scheduler, reporting tools, and exception management. Additionally, Celona provides Application Adaptors that facilitate the integration of multiple business applications during the migration from legacy systems to new platforms. The company serves various sectors, including telecommunications, financial services, utilities, retail, and the public sector, while addressing the needs of applications related to billing, CRM, ERP, and inventory management. Founded in 2005 and headquartered in London, Celona Technologies has expanded its presence with offices across Europe and the Asia Pacific.

Vivacta

Venture Round in 2009
Vivacta Limited is a medical diagnostics company based in Sittingbourne, UK, specializing in point-of-care testing solutions. The company has created an innovative piezofilm technology platform that enhances the development of near-patient diagnostic products, achieving sensitivity and dynamic range comparable to laboratory tests. Vivacta has successfully developed a diagnostic test for thyroid stimulating hormone (TSH) and is currently focused on creating a multiple analyte cardiovascular diagnostic test. This test aims to facilitate rapid diagnosis in emergency and acute care settings, addressing the urgent need for timely detection of potential heart attacks and related medical conditions.

OMGPOP

Series B in 2009
OMGPOP is a prominent developer of social games, specializing in interactive experiences across platforms such as Facebook, iPhone, and the open web. The company offers a diverse range of games that facilitate real-time engagement among players. In addition to its gaming offerings, OMGPOP features an online platform where users can chat, share photos, and forge new friendships. The company also retails various virtual items, including accessories and game-related products, enhancing the overall gaming experience for its community. With its focus on social connectivity and entertainment, OMGPOP has established itself as a leader in the online gaming industry.

Mind Candy

Convertible Note in 2009
Mind Candy Ltd. is a multi-brand entertainment company based in London, United Kingdom, that specializes in developing online games tailored for children and their families. Founded in 2003, the company is best known for its flagship product, Moshi Monsters, an online browser-based game that engages kids through interactive gameplay. In addition to Moshi Monsters, Mind Candy offers Moshi Monsters Village, a mobile gaming application, and Moshi Monsters Magazine, which features puzzles, stories, competitions, and crafts for children. The company also provides various applications, including Moshi Monsters Music and Moshling, which introduce users to whimsical creatures and musical experiences. Recently, Mind Candy expanded its offerings to include a sleep and mindfulness app for kids, incorporating melodic stories and guided meditation to promote relaxation and mindfulness.

Antenova

Venture Round in 2008
Antenova Ltd specializes in the design, development, and supply of standard and custom antennas, as well as radio frequency antenna modules for a variety of applications. The company's products cater to the wireless machine-to-machine (M2M) and Internet of Things (IoT) sectors, along with consumer electronic devices. Antenova's offerings include specialized antennas for WLAN, Wi-Fi, GPS, and telecom applications, and encompass various product lines such as gigaNOVA, RADIONOVA, and ceriiANT. The company also provides integration services, antenna matching and testing, and custom antenna design alongside sales and technical support. Antenova's solutions are utilized across diverse sectors, including automotive, healthcare, wearables, industrial, and smart city technologies. Established in 1999, the company is headquartered in Hatfield, United Kingdom, with design and sales centers in Taipei, Chicago, and Shanghai, and manufacturing operations in Taiwan and China. Its products are distributed through a global network of distributors.

Secerno

Series B in 2008
Secerno is a technology leader in active database control, headquartered in Oxford, UK, with a US office in Bedminster, New Jersey. The company specializes in database security and compliance software, offering innovative solutions to protect against both known and unknown threats. Its flagship product, Secerno DataWall™, provides comprehensive database activity monitoring, policy enforcement, and compliance auditing. These solutions are designed to safeguard data access in various sectors, including financial services, healthcare, pharmaceuticals, retail, and government agencies. Secerno's offerings are available as both hardware and virtual appliances, ensuring flexibility in deployment to meet diverse customer needs.

Celoxica

Venture Round in 2008
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Haemostatix

Venture Round in 2008
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Kobalt

Series B in 2008
Kobalt is an independent music services company that provides alternatives to traditional music business models. It focuses on music publishing, label services, and neighboring rights divisions, offering innovative technology solutions aimed at enhancing efficiency and transparency in the music industry. By empowering artists, songwriters, publishers, and labels, Kobalt ensures that each stakeholder is compensated fairly and accurately, navigating the complexities of digital micropayments. The company serves over 8,000 artists and songwriters, managing approximately 600,000 songs and collaborating with more than 450 publishing companies. With a global workforce of over 275 employees, Kobalt delivers real-time reporting through its award-winning Kobalt Portal and offers a range of services, including global licensing management, royalty collection, creative services, and digital marketing. The company represents many prominent artists and songwriters, contributing significantly to the charts in both the US and UK.

Blinkbox Music

Series A in 2008
blinkbox music is an ad-supported music streaming service and integrated MP3 store that offers users an accessible way to enjoy music. Launched in 2007 and based in Oxford, it allows listeners to choose from thousands of themed stations, such as Top 40 Songs and Ultimate 80s Pop, or to create their own stations based on specific songs, artists, or genres. The service is available for free on the web and through mobile and tablet apps for both Android and iOS. Users can also save their favorite stations for offline listening, enhancing the convenience of the platform.

Vivacta

Series B in 2007
Vivacta Limited is a medical diagnostics company based in Sittingbourne, UK, specializing in point-of-care testing solutions. The company has created an innovative piezofilm technology platform that enhances the development of near-patient diagnostic products, achieving sensitivity and dynamic range comparable to laboratory tests. Vivacta has successfully developed a diagnostic test for thyroid stimulating hormone (TSH) and is currently focused on creating a multiple analyte cardiovascular diagnostic test. This test aims to facilitate rapid diagnosis in emergency and acute care settings, addressing the urgent need for timely detection of potential heart attacks and related medical conditions.

Skinkers

Series B in 2007
Skinkers is a UK-based software developer specializing in communication management solutions. The company focuses on overcoming the limitations of existing digital channels by providing a peer-to-peer network designed for live video streaming and real-time notifications. Skinkers is known for its product Livestation, which streams live video from various official channels, including major news networks. Users can also add their own channels, enhancing the platform's versatility. The company holds the intellectual property rights for technology developed by Microsoft Research, with which it has a strategic partnership, including a minority equity stake from Microsoft. Skinkers aims to establish itself in the competitive peer-to-peer IPTV market, positioning itself against other emerging players in the industry.

EDEM Simulation

Venture Round in 2007
EDEM develops and markets discrete element method (DEM) simulation software, which serves as a critical tool for simulation-based engineering in industries that handle bulk materials, including powders, granules, and aggregates. Its software is utilized across numerous sectors such as pharmaceuticals, food processing, mining, and construction, allowing companies to optimize equipment design and performance, reduce operational costs, and accelerate product development. Founded in 2003 and headquartered in Edinburgh, EDEM also has offices in Denver, Yokohama, and Shenzhen, facilitating direct sales in major markets and supporting a global network of engineering service partners. The company offers advanced simulation solutions, including the EDEM software platform and EDEM BulkSim, along with engineering support services, aimed at enhancing productivity and innovation for clients worldwide.

Skinkers

Series A in 2007
Skinkers is a UK-based software developer specializing in communication management solutions. The company focuses on overcoming the limitations of existing digital channels by providing a peer-to-peer network designed for live video streaming and real-time notifications. Skinkers is known for its product Livestation, which streams live video from various official channels, including major news networks. Users can also add their own channels, enhancing the platform's versatility. The company holds the intellectual property rights for technology developed by Microsoft Research, with which it has a strategic partnership, including a minority equity stake from Microsoft. Skinkers aims to establish itself in the competitive peer-to-peer IPTV market, positioning itself against other emerging players in the industry.

StrategyEye

Series A in 2007
StrategyEye operates a B2B intelligence platform that combines proprietary content with relevant global news and blog sources, organizing information by a structured taxonomy that includes companies, categories, and trigger events. The company offers two main solutions: content marketing and content monetization. Its content marketing services assist brands in becoming publishers by identifying breaking stories and enabling them to create and distribute their own content through various channels, enhancing thought leadership and supporting SEO efforts. In terms of content monetization, StrategyEye aids publishers and event organizers in developing premium B2B intelligence products, facilitating additional revenue through subscriptions and online advertising. The company provides a comprehensive service that includes editorial workflow, structured taxonomies, and output templates. StrategyEye's clientele includes notable organizations such as Haymarket, IPC, and TimeWarner, and it also produces its own intelligence products focused on the Digital Media and Cleantech sectors, which are offered to a global audience of executives and advisors on a subscription basis.

Mind Candy

Series A in 2006
Mind Candy Ltd. is a multi-brand entertainment company based in London, United Kingdom, that specializes in developing online games tailored for children and their families. Founded in 2003, the company is best known for its flagship product, Moshi Monsters, an online browser-based game that engages kids through interactive gameplay. In addition to Moshi Monsters, Mind Candy offers Moshi Monsters Village, a mobile gaming application, and Moshi Monsters Magazine, which features puzzles, stories, competitions, and crafts for children. The company also provides various applications, including Moshi Monsters Music and Moshling, which introduce users to whimsical creatures and musical experiences. Recently, Mind Candy expanded its offerings to include a sleep and mindfulness app for kids, incorporating melodic stories and guided meditation to promote relaxation and mindfulness.

Skinkers

Seed Round in 2006
Skinkers is a UK-based software developer specializing in communication management solutions. The company focuses on overcoming the limitations of existing digital channels by providing a peer-to-peer network designed for live video streaming and real-time notifications. Skinkers is known for its product Livestation, which streams live video from various official channels, including major news networks. Users can also add their own channels, enhancing the platform's versatility. The company holds the intellectual property rights for technology developed by Microsoft Research, with which it has a strategic partnership, including a minority equity stake from Microsoft. Skinkers aims to establish itself in the competitive peer-to-peer IPTV market, positioning itself against other emerging players in the industry.

Haemostatix

Venture Round in 2005
Haemostatix Ltd., founded in 2003 and based in Nottingham, United Kingdom, specializes in developing a peptide-based platform technology aimed at addressing surgical bleeding and advancing tissue repair and regenerative medicine. The company originated as a spin-out from the University of Leicester and was co-founded by Sarah Middleton and Professor Alison Goodall. Its product pipeline includes PeproStat, a coagulant applied directly to wounds to effectively manage bleeding during surgical procedures. Haemostatix also focuses on creating various forms of hemostats, including liquid and transparent gel formulations, which enhance the speed and safety of bleeding control for healthcare professionals. As of May 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Aspex Semiconductor

Series B in 2004
Aspex Semiconductor is a fabless semiconductor company that develops, manufactures, and distributes system-on-chip high-definition video compression and transcoding solutions for consumer electronic applications. It is specialized in the development of software programmable media processors and offers HD video transcoding chips. Aspex Semiconductor’s products are used in intelligent home gateways, PVR functionalities, Blu-ray or HD DVD recorders, networked digital televisions, television pause buttons, PCs and laptops, HD webcams, external adapters, and wireless HDMI applications. The company serves professional imaging and wireless infrastructure markets, including broadcast and digital cinema, medical imaging, machine vision, printing and document processing, and video compression markets. Aspex Semiconductor is based in Bradford, Somerset and, it sells its products through distributors in North America and the United Kingdom.

Xention

Venture Round in 2003
Xention Limited is a biopharmaceutical company based in Cambridge, United Kingdom, that focuses on discovering and developing innovative ion channel-modulating drugs. Founded in 2002, the company aims to address significant unmet medical needs by creating therapies for conditions such as atrial fibrillation, overactive bladder, pain, and autoimmune diseases. Xention develops drug candidates that target two novel yet well-characterized ion channels, striving to produce breakthrough therapies that enhance treatment options in these areas. The company, originally known as Xention Discovery Ltd., rebranded to Xention Limited in October 2006.

Touch Clarity

Seed Round in 2000
Touch Clarity is a software company focused on enhancing customer acquisition and revenue for large consumer websites through content targeting solutions. The company specializes in developing tools that automatically build profile data on website visitors, allowing businesses to tailor their content offerings in real time. This continuous observation of online behavior enables Touch Clarity's software to adapt dynamically to changing user interactions and preferences. Additionally, the company provides enterprise web analytics that empower clients to generate comprehensive reports, further optimizing their online presence and efficiency. Through these services, Touch Clarity aims to measurably increase revenue and profit for its clients.

LinkGuard

Venture Round in 2000
LinkGuard's current and future technology solutions focus on the detection, reporting, repair, bypass and prevention of broken links on the Internet.

Aspex Semiconductor

Series A in 2000
Aspex Semiconductor is a fabless semiconductor company that develops, manufactures, and distributes system-on-chip high-definition video compression and transcoding solutions for consumer electronic applications. It is specialized in the development of software programmable media processors and offers HD video transcoding chips. Aspex Semiconductor’s products are used in intelligent home gateways, PVR functionalities, Blu-ray or HD DVD recorders, networked digital televisions, television pause buttons, PCs and laptops, HD webcams, external adapters, and wireless HDMI applications. The company serves professional imaging and wireless infrastructure markets, including broadcast and digital cinema, medical imaging, machine vision, printing and document processing, and video compression markets. Aspex Semiconductor is based in Bradford, Somerset and, it sells its products through distributors in North America and the United Kingdom.

Event Zero

Series A in 2000
Event Zero Pty Ltd, founded in 2005 and headquartered in Eight Mile Plains, Australia, specializes in online content management and software solutions aimed at enhancing IT service operations. The company offers a platform that encompasses data management, business consulting, and interactive article publishing, along with conferencing services. As an independent software vendor, Event Zero focuses on providing products that deliver insights and intelligence, particularly for Microsoft Lync unified communications and green IT initiatives. In 2016, Event Zero became a subsidiary of Microsoft Corporation, further enhancing its capabilities within the technology sector.

Nomad Payments

Private Equity Round in 2000
Nomad Payments is a leading provider of prepaid and debit card processing and licensed software.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.